Skip to main content
SpringerLink
Log in

Dabigatran, warfarin ranked top for risk in 2011

  • Incidence study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Institute for Safe Medication Practices.Anticoagulants the Leading Reported Drug Risk in 2011. Internet Document: [25 pages], 31 May 2012. Available from: URL: http://www.ismp.org/quarterwatch/pdfs/2011q4.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dabigatran, warfarin ranked top for risk in 2011. React. Wkly. 1406, 1 (2012). https://doi.org/10.2165/00128415-201214060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214060-00001

Keywords

Search

Navigation